MEN1309 I.v. Infusion in Pts With CD205-positive Metastatic Solid Tumors and Relapsed or Refractory NHL Ph I Study

NCT03403725 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
28
Enrollment
INDUSTRY
Sponsor class

Stopped Terminated after achievement of MTD, without progressing to cohort expansion for Company decision.

Conditions

Interventions

Sponsor

Menarini Group